Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 3979461)

Published in Cell Stem Cell on April 03, 2014

Authors

Chuanfeng Wu1, Brian Li1, Rong Lu2, Samson J Koelle1, Yanqin Yang3, Alexander Jares1, Alan E Krouse1, Mark Metzger1, Frank Liang4, Karin Loré4, Colin O Wu5, Robert E Donahue1, Irvin S Y Chen6, Irving Weissman2, Cynthia E Dunbar1

Author Affiliations

1: Hematology Branch; National Heart, Lung and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA.
2: Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
3: DNA Sequencing and Genomics Core; National Heart, Lung and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA.
4: Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.
5: Office of Biostatistics Research, National Heart, Lung and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA.
6: UCLA AIDS Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Articles citing this

In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases. Cell Stem Cell (2016) 0.93

Emerging insights into natural killer cells in human peripheral tissues. Nat Rev Immunol (2016) 0.91

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations. Front Immunol (2016) 0.89

Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems. Hum Gene Ther Methods (2015) 0.85

DNA barcoding reveals diverse growth kinetics of human breast tumour subclones in serially passaged xenografts. Nat Commun (2014) 0.83

Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent from HSPC. Blood (2016) 0.83

A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets. Immunity (2016) 0.83

Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells. Blood (2017) 0.82

Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand? Hum Gene Ther (2016) 0.79

MicroRNA-29b mediates altered innate immune development in acute leukemia. J Clin Invest (2016) 0.78

CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo. PLoS Pathog (2017) 0.77

No monkeying around: clonal tracking of stem cells and progenitors in the macaque. Cell Stem Cell (2014) 0.76

Transcriptome analysis reveals similarities between human blood CD3(-) CD56(bright) cells and mouse CD127(+) innate lymphoid cells. Sci Rep (2017) 0.75

Orphan NKs! The mystery of the self-renewing NK cells. Blood (2017) 0.75

Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin(-)CD34(+)DNAM-1(bright)CXCR4(+) Cell Progenitor. Front Immunol (2017) 0.75

Haematopoietic stem cells show their true colours. Nat Cell Biol (2016) 0.75

Transplantation Dose Alters the Differentiation Program of Hematopoietic Stem Cells. Cell Rep (2016) 0.75

Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets. Front Immunol (2016) 0.75

Microchimerism and regulation in living related kidney transplant families. Chimerism (2014) 0.75

Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells. Front Immunol (2017) 0.75

Quantitative Stability of Hematopoietic Stem and Progenitor Cell Clonal Output in Transplanted Rhesus Macaques. Blood (2017) 0.75

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset. Front Immunol (2017) 0.75

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A(+++) Cells, and Yet Display Increased Degranulation and Higher Perforin Content. Front Immunol (2017) 0.75

Articles cited by this

Purification and characterization of mouse hematopoietic stem cells. Science (1988) 15.99

Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell (1997) 12.60

Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (1996) 12.54

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science (2009) 8.80

Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68

Human natural killer cells. Blood (2008) 7.37

Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature (1990) 4.62

Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med (1996) 4.42

Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A (1992) 4.28

Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev (1990) 4.17

Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol (2005) 3.98

Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding. Nat Biotechnol (2011) 3.81

Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell (2007) 3.59

Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science (2005) 3.58

Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity (1995) 3.51

Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A (2002) 3.50

The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest (2009) 3.34

Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest (2007) 3.28

Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol (2010) 3.27

Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A (1991) 3.14

Hematopoiesis: a human perspective. Cell Stem Cell (2012) 2.87

Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest (2007) 2.80

Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood (2002) 2.69

The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood (2008) 2.66

Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol (2001) 2.63

Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat Immunol (2006) 2.60

Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther (2009) 2.56

Polyclonal long-term repopulating stem cell clones in a primate model. Blood (2002) 2.53

Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther (2006) 2.34

Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci U S A (2007) 2.30

Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood (2005) 2.27

Evidence that hematopoiesis may be a stochastic process in vivo. Nat Med (1996) 2.26

Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med (2009) 2.19

Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature (2013) 2.19

Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood (1997) 2.15

Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. Blood (2008) 2.06

Hematopoietic stem cell heterogeneity takes center stage. Cell Stem Cell (2012) 1.94

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood (2013) 1.93

Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell (2010) 1.87

Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood (2010) 1.81

Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood (2011) 1.76

CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood (2010) 1.70

The replication rate of human hematopoietic stem cells in vivo. Blood (2011) 1.58

Dissecting T cell lineage relationships by cellular barcoding. J Exp Med (2008) 1.53

Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology (2005) 1.50

Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood (2011) 1.45

Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34+ cells. Blood (2009) 1.35

Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics (2012) 1.35

Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood (2003) 1.34

Hematopoietic stem-cell behavior in nonhuman primates. Blood (2007) 1.27

Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells. J Virol (2009) 1.26

Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood (2000) 1.25

Heterogeneity of young and aged murine hematopoietic stem cells revealed by quantitative clonal analysis using cellular barcoding. Blood (2013) 1.23

Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells. Hum Gene Ther (2001) 1.21

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood (2007) 1.17

Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays. Oncogene (2004) 1.16

Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice. Blood (2013) 1.13

Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood (2005) 1.11

In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc (2008) 1.09

Large animal models for stem and progenitor cell analysis. Curr Protoc Immunol (2005) 1.06

Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy. Mol Ther (2011) 1.04

Dynamics of HSPC repopulation in nonhuman primates revealed by a decade-long clonal-tracking study. Cell Stem Cell (2014) 1.02

High efficiency restriction enzyme-free linear amplification-mediated polymerase chain reaction approach for tracking lentiviral integration sites does not abrogate retrieval bias. Hum Gene Ther (2012) 0.98

High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vector. Mol Ther (2012) 0.98

Human and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers. Blood (2010) 0.96

Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation. Immunology (2011) 0.91

Differential engraftment of genetically modified CD34(+) and CD34(-) hematopoietic cell subsets in lethally irradiated baboons. Exp Hematol (2000) 0.77